KickCancer Clinical Investigator Grants 2026

Financing description

On the initiative of KickCancer, a Foundation of public interest established in 2017 whose mission is to cure children with cancer, max. 2  KickCancer Clinical Investigator Grants (KCIG) will be granted in 2026 in the field of pediatric haemato-oncology in Belgium.

Main features 

• The KCIG intends to allow clinicians to devote half of their working time to carry research activities in pediatric haemato-oncology and provide a substitute to perform the clinical duties .
• The grant amounts to a maximum of EUR 70,000/year  (on-call duties and overhead excluded) to support the hiring of a substitute for the clinical duties.
• In addition to the EUR 70,000/year, an amount of max. EUR 10,000/year will be available as compensation for other costs (bench fees) associated with the Grant.
• The KCIG duration is 2 years renewable 4 times max. Upon the positive evaluation of a biennial progress report. Former grantees are entitled to reapply an unlimited number of times.
• The Grant must effectively start max. 12 months after the official starting date set to 1 ^st  October 2026. The effective start of the Grant corresponds to the hiring date of the grantee substitute.

Eligibility criteria  

• Eligible projects encompass any basic (hypothesis-driven) or translational research project or active participation in international clinical trials groups.
• Eligible applicants must:
  • Hold a recognized academic degree of Medical Doctor at the deadline of the call.
  • Be employed in one of the eligible organizations and commit to at least 80% FTE at the official start of the KCIG.
  • Hold a specialty in haemato-oncology (ending with reference code #698 under the RIZIV/INAMI nomenclature of healthcare services) and/or be (or commit to become) affiliated to the Belgian Society of Pediatric Haematology Oncology (BSPHO) at the official start of the KCIG.
• Eligible organizations encompass any university hospital attached to a university in Belgium, provided that they have a pediatric haemato-oncology department, as defined by the Royal Decree of April 2, 2014.
• The KCIG cannot be combined with the FNRS clinical researchers’ mandates.

Call timeline 

• Opening of the call: 1 ^st  December 2025
• Call deadline: 2 ^n/a  March 2026
• Panel meetings: 28 ^th  May 2026
• Start of the Grant: 2 ^n/a  October 2026

How to apply? 

Applications, written in English, must be submitted via the online application system available on www.kcig.be we 2 ^n/a  March 2026 (midnight CET) at the latest.

• Tea complete regulations  of the KCIG 2026 are available here.
• Tea guide for applicants  is available here.

Questions about the KCIG should be addressed via email to prix@frs-fnrs.be. 

Mini-guide

Tea guide for applicants  is available here .

Regulations

Tea complete regulations  of the KCIG 2026 are available here .